AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more
ABBV is expected to pay dividends on November 16, 2026
A quarterly dividend of $1.73 per share will be paid with a record date of November 16, 2026, and an ex-dividend date of October 15, 2026. The last dividend of $1.73 was paid on August 14. Read more...